Cherries and Fatty Liver: Benefits and Evidence

Cherries and fatty liver disease is a topic of growing interest, as research suggests this antioxidant-rich fruit may offer modest support for liver health. Fatty liver disease, now more formally termed metabolic dysfunction-associated steatotic liver disease (MASLD), affects an estimated one in three to one in four adults in the UK and is closely linked to obesity, type 2 diabetes and metabolic syndrome. Cherries contain bioactive compounds including anthocyanins, quercetin and dietary fibre, which may help reduce liver inflammation and oxidative stress. However, no single food can treat fatty liver disease, and dietary changes should always complement professional medical guidance.

Can eating cherries help with fatty liver disease?

Cherries may offer modest support for liver health as part of a balanced diet, but they are not a treatment for fatty liver disease and cannot replace medical management of MASLD.

Cherries may offer modest support for liver health as part of a balanced, calorie-controlled diet, though they are not a treatment for fatty liver disease and should not replace medical advice. Fatty liver disease is known clinically as metabolic dysfunction-associated steatotic liver disease (MASLD), though UK guidance including NICE guideline NG49 and NHS patient information still commonly uses the older term non-alcoholic fatty liver disease (NAFLD). Both terms refer to the same condition, in which excess fat accumulates in liver cells. It affects an estimated one in three to one in four adults in the UK, according to the British Liver Trust, and is closely linked to obesity, type 2 diabetes and metabolic syndrome.

Cherries are a nutrient-dense fruit containing antioxidants, anti-inflammatory compounds and dietary fibre, all of which may contribute to a liver-supportive dietary pattern. However, no single food can reverse fatty liver disease. The condition is best managed through sustained lifestyle changes, including dietary improvement, increased physical activity and, where appropriate, medical intervention.

If you have been diagnosed with fatty liver disease, your GP or a hepatologist should guide your management plan. A referral to a dietitian may also be helpful for personalised nutritional advice. For further patient information, the British Liver Trust and the NHS NAFLD page offer accessible UK-focused resources. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, which may be relevant for those whose fatty liver is linked to excess weight.

What does the evidence say about cherries and liver health?

Preclinical studies and small human trials suggest tart cherries may reduce liver inflammation markers, but no robust randomised controlled trial has confirmed clinical benefit in people with MASLD.

Preclinical and early human research suggests that cherry consumption may have a beneficial effect on markers of liver inflammation and fat accumulation, though the evidence in humans remains limited and preliminary. Much of the available data comes from animal studies and small-scale laboratory investigations, which means firm conclusions cannot yet be drawn for clinical practice.

Several studies have examined tart cherries (Prunus cerasus) in particular. Research in rodent models has found that tart cherry supplementation reduced hepatic fat content and lowered markers of oxidative stress. A small number of human studies have explored the effect of tart cherry juice on inflammatory biomarkers, with some reporting reductions in C-reactive protein (CRP) and other inflammatory markers. These findings are relevant to liver health given the role of chronic inflammation in MASLD progression, but the studies involved small populations, short durations and varied methodologies, limiting how much weight can be placed on them.

Importantly, no robust randomised controlled trial in humans has demonstrated that cherry consumption improves liver histology or fibrosis in people with diagnosed MASLD or NAFLD. Sweet cherries (Prunus avium), which are more commonly consumed in the UK, have been less extensively studied in the context of liver disease specifically, though they share many of the same bioactive compounds.

Overall, the current evidence is encouraging but not yet sufficient to support specific clinical recommendations. Larger, well-designed randomised controlled trials in humans are needed to clarify whether any benefit is meaningful and durable. In the meantime, cherries can reasonably be included as part of a varied, fruit-rich diet that supports overall metabolic health.

Which compounds in cherries may support a healthy liver?

Anthocyanins, quercetin, melatonin and dietary fibre are the key bioactive compounds in cherries that may reduce oxidative stress and liver inflammation, though most evidence comes from preclinical studies.

Cherries contain several bioactive compounds that may contribute to liver health, most notably anthocyanins, quercetin, melatonin and dietary fibre. It is important to note that most of the mechanistic evidence for these compounds comes from preclinical (in vitro and animal) studies; human evidence remains early-stage.

Anthocyanins are the pigments responsible for the deep red colour of cherries and belong to the flavonoid family of polyphenols. They have demonstrated antioxidant and anti-inflammatory properties in laboratory settings, and oxidative stress is a key driver of liver cell damage in MASLD.^[12] Quercetin, another flavonoid present in cherries, has been studied in preclinical models for its potential to inhibit lipid accumulation in liver cells and reduce inflammatory signalling pathways.^[13] Melatonin, found in small amounts in tart cherries, has attracted interest for its antioxidant properties and its possible role in protecting liver tissue from oxidative injury, though human evidence remains very limited.

Dietary fibre, present in whole cherries, supports gut health and may indirectly benefit the liver through the gut-liver axis. A healthy gut microbiome is increasingly recognised as important in the regulation of liver fat metabolism and inflammation. Cherries also have a relatively low glycaemic index compared with many other fruits, meaning they cause a more gradual rise in blood glucose. This is relevant for people with insulin resistance, a common driver of fatty liver disease, though portion size remains important.

These compounds are found across a wide range of fruits and vegetables, and the overall dietary pattern matters more than any single food source. Evidence from systematic reviews consistently associates a Mediterranean-style dietary pattern, rich in diverse plant foods, wholegrains, legumes and oily fish, with better liver health outcomes. This is reflected in guidance from the European Association for the Study of the Liver (EASL).

Finally, it is worth clarifying that the evidence discussed here relates to whole cherries consumed as part of a balanced diet. Cherry supplements or extracts are not equivalent and are not recommended without specific advice from a clinician or dietitian.

How many cherries should you eat as part of a liver-friendly diet?

There is no specific evidence-based recommendation; including one NHS 5 A Day portion of approximately 14 cherries (80 g) as part of a varied diet is a practical approach.

There is no specific evidence-based recommendation for the number of cherries to eat to support liver health. Including cherries as part of the NHS-recommended five portions of fruit and vegetables per day is a practical starting point. According to NHS 5 A Day guidance, a standard portion of cherries is approximately 14 cherries (around 80 g).

Some research studies have used tart cherry concentrate or juice in quantities intended to reflect a high intake of tart cherries, though the exact amounts vary between trials and the products used differ from commercially available juices. These are research doses used in specific study protocols and are not clinical recommendations; they should not be replicated without professional guidance.

Whole cherries are preferable to juice for most people, as they retain their dietary fibre and have a lower glycaemic impact. NHS 5 A Day guidance notes that a 150 ml glass of unsweetened fruit juice counts as a maximum of one portion per day, regardless of how much is consumed, and does not provide the same fibre benefit as whole fruit.^[4] Fresh and frozen cherries are broadly comparable nutritionally. Canned cherries can be a convenient option, but it is worth checking the label: choose fruit canned in juice rather than syrup, and drain before eating, as canning can affect vitamin C content and added sugar levels.

Cherries should be viewed as one component of a broader liver-friendly dietary pattern rather than a standalone remedy. Key dietary principles for MASLD management, as supported by NICE guideline NG49 and EASL clinical practice guidance, include reducing overall calorie intake, limiting saturated fat, refined carbohydrates and added sugars, and increasing consumption of vegetables, wholegrains, legumes and oily fish.

What else can you do alongside diet to manage fatty liver?

Sustained weight loss of 7 to 10 per cent, regular physical activity, alcohol reduction and GP-led monitoring are the most evidence-based interventions for managing fatty liver disease alongside dietary changes.

When to seek urgent help: Some symptoms associated with liver disease require prompt medical attention. Contact your GP or call NHS 111 the same day if you develop jaundice (yellowing of the skin or whites of the eyes), new or worsening abdominal swelling, or persistent severe pain in the upper right abdomen. Call 999 or go to A&E immediately if you vomit blood, pass black or tarry stools, or experience sudden confusion or extreme drowsiness, as these may indicate serious complications requiring emergency assessment.

Sustained weight loss is the most evidence-based lifestyle intervention for improving fatty liver disease. NICE guideline NG49 indicates that a reduction of 7 to 10 per cent of body weight is associated with meaningful improvements in liver fat and inflammation. Even modest weight loss of 3 to 5 per cent can reduce hepatic steatosis, though greater reductions are generally needed to improve fibrosis.^[1]

Regular physical activity is independently beneficial for liver health, even without significant weight loss. Both aerobic exercise and resistance training have been shown to reduce liver fat content. UK Chief Medical Officers' guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week, alongside muscle-strengthening activities on two or more days per week.^[5][6] Activities such as brisk walking, cycling and swimming are accessible options for most adults.

Alcohol reduction or abstinence is important for anyone with fatty liver disease, as alcohol can accelerate liver damage even in those whose primary diagnosis is metabolic rather than alcohol-related. UK Chief Medical Officers' low-risk drinking guidelines advise keeping alcohol consumption to no more than 14 units per week, spread over three or more days, with several alcohol-free days each week.^[7] People with MASLD should discuss their alcohol intake honestly with their GP.

For individuals whose fatty liver is linked to obesity, a structured weight-management programme may be appropriate. In some cases, a GP may refer to specialist services or consider pharmacological support. Any medicines used in weight management are only appropriate where clinically indicated and should be discussed with a healthcare professional.

In UK primary care, NICE NG49 recommends that people with suspected NAFLD or MASLD are assessed using a FIB-4 score or NAFLD Fibrosis Score to estimate the risk of advanced fibrosis. Those with an indeterminate or high-risk score may be referred for enhanced liver fibrosis (ELF) testing or transient elastography (FibroScan). People in whom advanced fibrosis is suspected should be referred to hepatology. Your GP will advise on the appropriate pathway for your circumstances.

Regular monitoring is also important. Your GP may arrange periodic liver function tests and, where indicated, imaging or non-invasive fibrosis assessment to track disease progression. If you experience symptoms such as persistent fatigue, right-sided abdominal discomfort or unexplained weight loss, contact your GP promptly rather than waiting for a routine review.

Scientific References

1. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49).
2. Non-alcoholic fatty liver disease (NAFLD).
3. 5 A Day portion sizes.
4. 5 A Day: what counts?.
5. Physical activity guidelines: UK Chief Medical Officers' report.
6. Physical activity guidelines for adults aged 19 to 64.
7. Alcohol consumption: advice on low risk drinking.
8. Mediterranean diet and metabolic outcomes in NAFLD/MASLD: a systematic review and meta-analysis of randomized controlled trials.
9. The impact of dietary interventions on liver health biomarkers in individuals with MASLD: a systematic literature review and meta-analysis of randomized controlled trials.
10. Effects of Mediterranean diet, exercise, and their combination on body composition and liver outcomes in MASLD: a systematic review and meta-analysis of randomized controlled trials.
11. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease.
12. Anti-inflammatory and antioxidant effects of anthocyanins (including reduced hepatic steatosis).
13. Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signalling pathways.
14. Effects of Tart Cherry Juice on Biomarkers of Inflammation and Oxidative Stress in Older Adults.
15. The impact of long-term exercise on liver function, fatty liver progression, and related metabolic markers in NAFLD patients: a meta-analysis of randomized controlled trials.
16. Resistance training for metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.

Frequently Asked Questions